Grelan Pharmaceutical announced on April 26 that it has concluded a sales agreement with Teijin Pharma (TSE: 3401) for “Fenofibrate,” a lipid-lowering agent manufactured by French Fournier Pharma. Under this agreement, Grelan and Teijin will jointly promote and distribute a pulverized type (fine powder) of “Fenofibrate.”
